Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma

Melanoma Research

Volumn 19, Issue 4, 2009, Pages 243-251

  Solari, Nicola ^a,b   Gipponi, Marco ^b   Stella, Mattia ^a   Queirolo, Paola ^a   Di Somma, Carmine ^a   Villa, Giuseppe ^a   Piccardo, Arnoldo ^c   Gualco, Marina ^a   Cardinale, Francesco ^b   Cafiero, Ferdinando ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

Author keywords

Melanoma; Preoperative lymphatic mapping; Sentinel lymph node

Indexed keywords

DIAGNOSTIC AGENT; MACROSALB TC 99M;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; PEROPERATIVE CARE; PHYSIOLOGY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTRAOPERATIVE CARE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TUMOR BURDEN;

EID: 70349904635     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32832e0b9a     Document Type: Article

References (38)

1. Cascinelli N, Bombardieri E, Bufalino R, Camerini T, Carbone A, Clemente C, et al. Sentinel lymph node biopsy in cutaneous melanoma. The WHO melanoma program experience. Ann Surg Oncol 2000; 7:469-474. (Pubitemid 30439307)
2. Balch CM. The revised melanoma staging system: its use in the design and interpretation of melanoma clinical trials. In: Perry MC, editor. ASCO 2001 educational book. Alexandria (Virginia): 2001. pp. 82-87.
3. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001; 19:2851-2855. (Pubitemid 32538194)
4. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
5. Cascinelli N, Clemente C, Bifulco C, Tragni G, Morabito A, Santinami M, et al. Do patients with tumor-positive sentinel nodes constitute a homogeneous group? Ann Surg Oncol 2001; 8:35-37. (Pubitemid 32947425)
6. Starz H, Balda BR, Kramer KU, Buchels H,Wang HJ. A micromorphometrybased concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91:2110-2120.
7. Kleinhans E, Baumeister RGH, Hahn D, Siuda S, Buell U, Moser E. Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted lymphatic vessels. Eur J Nucl Med 1985; 10:349-352. (Pubitemid 15104338)
8. Weiss M, Baumeister RGH, Tatsch K, Hahn K. Lymphoscintigraphy for non invasive long-term follow-up after autogenous lymph vessel transplantation. 43rd Annual Meeting of the Society of Nuclear Medicine, June 1996, Denver/Colorado, USA. J Nucl Med 1996; 37:25P.
9. Prieto VG. Use of frozen sections in the examination of sentinel lymph nodes in patients with melanoma. Semin Diagn Pathol 2008; 25:112-115. (Pubitemid 351885455)
10. Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008; 25:100-111. (Pubitemid 351885456)
11. Valdés Olmos RA, Tanis PJ, Hoefnagel CA, Nieweg OE, Muller SH, Rutgers EJ, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22:579-586. (Pubitemid 32458188)
12. Karakousis CP, Velez AF, Spellman JE, Scarozza J. The technique of sentinel node biopsy. Eur J Surg Oncol 1996; 22:271-275. (Pubitemid 26229679)
13. Cafiero F, Peressini A, Percivale PL, Rainero ML, Faggioni M, Gipponi M, et al. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience. Anticancer Res 2000; 20:497-500. (Pubitemid 30189708)
14. Ordonez NG, Ji XL, Hockey RC. Comparison of HMB45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Histopathol 1986; 10:1315-1324.
15. WHO declares lymphatic mapping to be the standard of care for melanoma. Oncology 1999; 321:3-4.
16. Cole DJ, Baron PL. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection. Semin Oncol 1996; 23:719-724. (Pubitemid 26424698)
17. Slingluff CL, Vollmer RT, Reintgen DS, Seigler HF. Lethal thin malignant melanoma: identifying patients at risk. Ann Surg 1988; 208:150-161.
18. Crowley NJ, Seigler HF. The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. Cancer 1990; 66:2522-2527.
19. Ferrone CR, Panageas KS, Busam K, Brady MS, Coit DG. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 2002; 9:637-645. (Pubitemid 34857980)
20. Essner R, Chung MH, Bleicher R, Hsueh E, Wanek L, Morton DL. Prognostic implications of thick ( >4 mm) melanoma in the era of lymphatic mapping and sentinel lymphadenectomy. Ann Surg Oncol 2002; 9:754-761.
21. Thompson JF, McCarthy WH, Bosch CMJ. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5:255-260.
22. Glass LF, Meddina J, Glass J. The results of complete lymph node dissection in 88 melanoma patients with positive sentinel nodes. Melanoma Res 1997; 7 (Suppl 1):104.
23. Bostick P, Essner R, Glass E, Kelley M, Sarantou T, Foshag LJ, et al. Comparison of blue dye and probe assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basin. Arch Surg 1999; 134:43-49. (Pubitemid 29047212)
24. Pijpers R, Collet GR, Meijer S, Hoestra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995; 22:1238-1241.
25. Cochran AJ, Essner R, Rose DM, Glass EC. Principles of sentinel lymph node identification: background and clinical implications. Langenbecks Arch Surg 2000; 385:252-260.
26. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanoma of the head and neck. J Clin Oncol 1993; 11:1751-1756. (Pubitemid 23277328)
27. Heller R, King B, Baekey P, Cruse W, Reintgen D. Identification of submicroscopic lymph node metastases in patients with malignant melanoma. Semin Surg Oncol 1993; 9:285-289. (Pubitemid 23154469)
28. Cottingham T, Larson J, Delaney JP, Zachary C. Sentinel node dissection in the treatment of melanoma. Dermatol Surg 1997; 23:113-119.
29. Tanis PJ, Boom RP, Koops HS, Faneyte IF, Peterse JL, Nieweg OE, et al. Frozen section examination of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001; 8:222-226. (Pubitemid 32294802)
30. Sabel MS, Gibbs JF, Cheney R, McKinley BP, Lee JS, Krybill WG. Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute - designed cancer center. Surgery 2000; 128:556-553.
31. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol 2000; 7:469-474. (Pubitemid 30439307)
32. Doting MH, Hoekstra HJ, Plukker JT, Piers DA, Jager PL, Tiebosch AT, et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol 2002; 28:673-678.
33. Gipponi M, Solari N, Lionetto R, Di Somma C, Villa G, Schenone F, et al. The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group. Eur J Surg Oncol 2005; 31:1191-1197. (Pubitemid 41819207)
34. Chao C, Wong SL, Ross MI, Reintgen DS, Noyes RD, Cerrito PB, et al. Pattern of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002; 184:520-525. (Pubitemid 35477707)
35. Karakousis CP, Temple DF, Moore R, Ambrus JL. Prognostic parameters in recurrent malignant melanoma. Cancer 1983; 52:575-579. (Pubitemid 13073490)
36. Reintgen DS, Vollmer R, Tso CY, Seigler HF. Prognosis for recurrent stage I malignant melanoma. Arch Surg 1987; 122:1338-1342. (Pubitemid 18021293)
37. Reintgen DS, Cox C, Slingluff CL, Seigler HF. Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg 1992; 28:45-49.
38. Statius Muller MG, van Leeuwen PA, van Diest PJ, Pijpers R, Nijveldt RJ, Vuylsteke RJ, et al. Pattern and incidence of first site recurrence following sentinel node procedure in melanoma patients. World J Surg 2002; 26:1405-1411. (Pubitemid 36920195)